<生产厂家价格>

对氰基苯甲醛

对氰基苯甲醛用途

用作医药中间体

对氰基苯甲醛名称

[ CAS 号 ]:
105-07-7

[ 中文名 ]:
4-氰基苯甲醛

[ 英文名 ]:
4-Cyanobenzaldehyde

[中文别名 ]:

对氰基苯甲醛

[英文别名 ]:

4-cyano-benzaldehyde
4-Formylbenzolcarbonitril
4-Cyanobenzaldehyde
VHR DCN
p-Cyanobenzaldehyde
4-Cyanbenzaldehyd
4-cyanobenzalddhyde
USAF kf-1
USAF KP-1
4-Formylbenzonitrile

对氰基苯甲醛物理化学性质

[ 密度 ]:
1.2±0.1 g/cm3

[ 沸点 ]:
262.3±0.0 °C at 760 mmHg

[ 熔点 ]:
100102°C

[ 分子式 ]:
C₈H₅NO

[ 分子量 ]:
131.131

[ 闪点 ]:
124.2±22.6 °C

[ 精确质量 ]:
131.037109

[ PSA ]:
40.86000

[ LogP ]:
1.30

[ 外观性状 ]:
淡黄色粉末

[ 蒸汽压 ]:
0.0±0.5 mmHg at 25°C

[ 折射率 ]:
1.552

[ 储存条件 ]:
2-8°C

对氰基苯甲醛MSDS

对氰基苯甲醛毒性和生态

CHEMICAL IDENTIFICATION

RTECS NUMBER :: CU5250000

CHEMICAL NAME :: Benzaldehyde, p-cyano-

CAS REGISTRY NUMBER :: 105-07-7

LAST UPDATED :: 199701

DATA ITEMS CITED :: 2

MOLECULAR FORMULA :: C8-H5-N-O

MOLECULAR WEIGHT :: 131.14

WISWESSER LINE NOTATION :: VHR DCN

HEALTH HAZARD DATA

ACUTE TOXICITY DATA

TYPE OF TEST :: LD50 - Lethal dose, 50 percent kill

ROUTE OF EXPOSURE :: Intraperitoneal

SPECIES OBSERVED :: Rodent - mouse

DOSE/DURATION :: 100 mg/kg

TOXIC EFFECTS :: Details of toxic effects not reported other than lethal dose value

REFERENCE :: NTIS** National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific & Technical Information. Volume(issue)/page/year: AD277-689

对氰基苯甲醛安全信息

[ 符号 ]:

GHS07

[ 信号词 ]:
Warning

[ 危害声明 ]:
H302-H312-H332

[ 警示性声明 ]:
P280

[ 个人防护装备 ]:
dust mask type N95 (US);Eyeshields;Gloves

[ 危害码 (欧洲) ]:
Xn:Harmful

[ 风险声明 (欧洲) ]:
R20/21/22

[ 安全声明 (欧洲) ]:
S36/37

[ 危险品运输编码 ]:
3439

[ WGK德国 ]:
3

[ RTECS号 ]:
CU5250000

[ 包装等级 ]:
III

[ 危险类别 ]:
6.1

[ 海关编码 ]:
29269095

对氰基苯甲醛合成路线

对氰基苯甲醛上下游产品

对氰基苯甲醛上游产品

对氰基苯甲醛下游产品

对氰基苯甲醛海关

[ 海关编码 ]: 2926909090

[ 中文概述 ]:
2926909090 其他腈基化合物. 增值税率:17.0% 退税率:9.0% 监管条件:无最惠国关税:6.5% 普通关税:30.0%

[ 申报要素 ]: 品名, 成分含量, 用途

[ Summary ]:
HS:2926909090 other nitrile-function compounds VAT:17.0% Tax rebate rate:9.0% Supervision conditions:none MFN tariff:6.5% General tariff:30.0%

对氰基苯甲醛文献

Identification of novel CYP2A6 inhibitors by virtual screening

Bioorg. Med. Chem. 19 , 7186-93, (2011)

The human CYP2A6 enzyme metabolises several xenobiotics including nicotine, the addictive component in tobacco. Reduced activity of CYP2A6, either for genetic reasons or by administering inhibitors of...

更多文献